To hear about similar clinical trials, please enter your email below
Trial Title:
Effectiveness on Family Cohesion and Happiness of Using Social Media to Enhance Happiness Accounts for Late-Stage Cancer Patients and Their Families
NCT ID:
NCT06559917
Condition:
Cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
Single (Participant)
Intervention:
Intervention type:
Other
Intervention name:
life review
Description:
After consenting, they will complete the first questionnaire before receiving the
"Happiness Ledger" intervention via social media. Family members will have one week to
organize photos, after which patients will share the meaning of the photos. This process
will be recorded by the researcher and will last approximately 40 to 60 minutes. The
researcher will then create a three-minute video using the photos, and the participating
family members will assist in uploading the photos to the family LINE group as feedback
to the subjects. The second questionnaire will then be completed.
Arm group label:
Experimental Group
Summary:
The study period is from September 1, 2024, to December 31, 2025. The subjects are cancer
patients from the medical center of this hospital. A block randomization will be used to
assign 100 patients to the experimental group and 100 patients to the control group,
totaling 200 patients. During the study process, questionnaires and medical records of
the subjects will be collected. The experimental group will receive the social media
"Happiness Ledger" intervention, while the control group will receive routine treatment.
Questionnaires will be collected from both groups before and after the intervention.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Inclusion Criteria for Advanced Cancer Patients:
1. Patients diagnosed with stage III or IV cancer by a specialist physician.
2. Patients who agree to participate in the study after being informed about the
research.
3. Patients who are conscious and able to communicate in Mandarin or Taiwanese.
4. Patients aged 20 years or older.
5. Patients with no history of mental illness.
Inclusion Criteria for Family Members:
1. The primary caregiver of a patient diagnosed with stage III or IV cancer by a
specialist physician.
2. The primary caregiver who has a blood, marital, or cohabitation relationship with
the patient.
3. Family members who agree to participate in the study after being informed about the
research.
4. Family members who are conscious and able to communicate in Mandarin or Taiwanese.
5. Family members aged 20 years or older.
6. Family members with no history of mental illness.
Exclusion Criteria:
- Exclusion Criteria for Advanced Cancer Patients:
1. Patients in the experimental group and control group who reside in the same ward.
2. Patients who share a ward with subjects already included in the study.
3. Patients involved in ongoing medical disputes.
4. Patients who cannot understand the study explanation due to language or cognitive
impairments.
5. Patients with a life expectancy shorter than the planned study duration.
Exclusion Criteria for Family Members:
1. Family members who do not have direct living or caregiving contact with the patient.
2. Family members who cannot visit the patient regularly or participate in the study.
3. Family members who cannot understand the study explanation due to language or
cognitive impairments.
4. Family members with significant visual or hearing impairments who do not use
assistive devices and cannot resolve communication issues.
5. Family members who cannot make independent decisions.
Gender:
All
Minimum age:
20 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
September 1, 2024
Completion date:
December 31, 2025
Lead sponsor:
Agency:
YANG WEN-CHI
Agency class:
Other
Source:
Tri-Service General Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06559917
